 |
인쇄하기
취소
|
AstraZeneca seeking R&D potential in Korea
AstraZeneca (AZ), the world's sixth-largest pharmaceutical company, plans to select six Korean research teams to participate in the sixth Virtual Research Institute (VRI) from September 19 to October 19.
The selected VRI team will receive about $35,000 research fund to study a variety of new drug opportunities to address diseases like diabetes and arteriosclerosis.
The company's support f...
The selected VRI team will receive about $35,000 research fund to study a variety of new drug opportunities to address diseases like diabetes and arteriosclerosis.
The company's support f...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.